This compound is an active pharmaceutical ingredient with a spiro-oxathiolane-azabicyclooctane structure, available as a hydrochloride salt. It is used as a pharmaceutical intermediate in manufacturing processes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 107220-28-0
Ixazomib
pharmaceutical raw material
Methyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate
pharmaceutical raw material
Ziconotide
pharmaceutical raw material
Omadacycline tosylate
pharmaceutical raw material
(2R,5R)-2-methylspiro[1,3-oxathiolane-5,3'-1-azabicyclo[2.2.2]octane];hydrochloride
SURWTGAXEIEOGY-GHXDPTCOSA-N
C[C@@H]1O[C@]2(CN3CCC2CC3)CS1.Cl